Search This Blog

Tuesday, March 28, 2023

Evotec, Bristol Extend and Expand Strategic Neurodegeneration Partnership

 

  • 8-YEAR EXTENSION AND EXPANSION OF ONGOING COLLABORATION TO DEVELOP A BROADENED PROGRAMME PIPELINE IN NEURODEGENERATIVE DISEASES

  • PARTNERSHIP LEVERAGES EVOTEC'S PRECISION MEDICINE PLATFORMS

  • FINANICAL TERMS INCLUDE $ 50 M UPFRONT PAYMENT, PERFORMANCE MILESTONES AND TIERED ROYALTIES ON PRODUCT SALES

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)